Published in Mol Cell Biol on August 01, 1994
Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem (2009) 8.83
Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell (2009) 6.16
Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes. Mol Biol Cell (2000) 5.19
"Sleeping beauty": quiescence in Saccharomyces cerevisiae. Microbiol Mol Biol Rev (2004) 4.23
A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol (1995) 3.56
Two RING finger proteins mediate cooperation between ubiquitin-conjugating enzymes in DNA repair. EMBO J (2000) 3.46
The multiubiquitin-chain-binding protein Mcb1 is a component of the 26S proteasome in Saccharomyces cerevisiae and plays a nonessential, substrate-specific role in protein turnover. Mol Cell Biol (1996) 3.41
Ubiquitin lys63 is involved in ubiquitination of a yeast plasma membrane protein. EMBO J (1997) 3.24
p34Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol (1995) 3.23
Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature (2008) 3.11
RPN4 is a ligand, substrate, and transcriptional regulator of the 26S proteasome: a negative feedback circuit. Proc Natl Acad Sci U S A (2001) 2.85
Ubiquitin, hormones and biotic stress in plants. Ann Bot (2007) 2.77
Degradation of subunits of the Sec61p complex, an integral component of the ER membrane, by the ubiquitin-proteasome pathway. EMBO J (1996) 2.72
Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat Cell Biol (2005) 2.62
Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol (2012) 2.53
Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting. Proc Natl Acad Sci U S A (1996) 2.50
CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J Virol (1998) 2.38
Requirement of RAD5 and MMS2 for postreplication repair of UV-damaged DNA in Saccharomyces cerevisiae. Mol Cell Biol (2002) 2.37
Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol (2005) 2.17
Ubiquitination of the yeast a-factor receptor. J Cell Biol (1996) 2.06
Lysine 63-linked polyubiquitin chain may serve as a targeting signal for the 26S proteasome. EMBO J (2009) 1.93
TPR proteins required for anaphase progression mediate ubiquitination of mitotic B-type cyclins in yeast. Mol Biol Cell (1996) 1.92
TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem J (2005) 1.84
E3 ligase Nedd4 promotes axon branching by downregulating PTEN. Neuron (2010) 1.76
The ubiquitin-proteasome system of Saccharomyces cerevisiae. Genetics (2012) 1.73
The ubiquitin system, disease, and drug discovery. BMC Biochem (2008) 1.73
Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. EMBO J (2006) 1.64
Polyubiquitin-sensor proteins reveal localization and linkage-type dependence of cellular ubiquitin signaling. Nat Methods (2012) 1.62
Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis. J Virol (2002) 1.61
Sec61p-independent degradation of the tail-anchored ER membrane protein Ubc6p. EMBO J (2001) 1.50
Polyubiquitin linkage profiles in three models of proteolytic stress suggest the etiology of Alzheimer disease. J Biol Chem (2011) 1.48
Substrate degradation by the proteasome: a single-molecule kinetic analysis. Science (2015) 1.47
APC/C-mediated multiple monoubiquitylation provides an alternative degradation signal for cyclin B1. Nat Cell Biol (2012) 1.46
A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. Mol Syst Biol (2009) 1.43
Ubiquitin-mediated mRNP dynamics and surveillance prior to budding yeast mRNA export. Genes Dev (2010) 1.43
Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Mol Cell Proteomics (2010) 1.43
The 'destruction box' of cyclin A allows B-type cyclins to be ubiquitinated, but not efficiently destroyed. EMBO J (1996) 1.40
Retracted Detection of ubiquityl-calmodulin conjugates with a novel high-molecular weight ubiquitylprotein-isopeptidase in rabbit tissues. Eur J Med Res (2010) 1.39
Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain. Mol Cell Biol (2006) 1.39
S5a promotes protein degradation by blocking synthesis of nondegradable forked ubiquitin chains. EMBO J (2009) 1.36
Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies. J Virol (2007) 1.33
The DNA damage-inducible UbL-UbA protein Ddi1 participates in Mec1-mediated degradation of Ho endonuclease. Mol Cell Biol (2005) 1.30
Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo. J Biol Chem (2008) 1.29
Lys6-modified ubiquitin inhibits ubiquitin-dependent protein degradation. J Biol Chem (2005) 1.26
A perturbed ubiquitin landscape distinguishes between ubiquitin in trafficking and in proteolysis. Mol Cell Proteomics (2011) 1.25
Targeting of Sna3p to the endosomal pathway depends on its interaction with Rsp5p and multivesicular body sorting on its ubiquitylation. Traffic (2007) 1.24
The yeast ubiquitin ligase SCFMet30: connecting environmental and intracellular conditions to cell division. Cell Div (2006) 1.21
Elimination of defective alpha-factor pheromone receptors. Mol Cell Biol (1997) 1.19
The proteasome: a macromolecular assembly designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci (1999) 1.16
PPAR-gamma AF-2 domain functions as a component of a ubiquitin-dependent degradation signal. Obesity (Silver Spring) (2009) 1.09
Uncovering ubiquitin and ubiquitin-like signaling networks. Chem Rev (2011) 1.06
Targeting the UPS as therapy in multiple myeloma. BMC Biochem (2008) 1.05
Mechanisms for countering oxidative stress and damage in retinal pigment epithelium. Int Rev Cell Mol Biol (2012) 1.05
Quality control and fate determination of Hsp90 client proteins. Biochim Biophys Acta (2011) 1.04
Global approaches to understanding ubiquitination. Genome Biol (2005) 1.03
Glucose-induced monoubiquitination of the Saccharomyces cerevisiae galactose transporter is sufficient to signal its internalization. J Bacteriol (2001) 1.02
Degradation or maintenance: actions of the ubiquitin system on eukaryotic chromatin. Eukaryot Cell (2002) 1.00
Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment. Mol Cell Proteomics (2012) 1.00
Supramolecular complex formation between Rad6 and proteins of the p53 pathway during DNA damage-induced response. Mol Cell Biol (2003) 1.00
Sequential ubiquitination and deubiquitination enzymes synchronize the dual sensor and effector functions of TRIM21. Proc Natl Acad Sci U S A (2015) 0.99
Membrane protein targeting to the MVB/lysosome. Chem Rev (2009) 0.95
A Method to Identify p62's UBA Domain Interacting Proteins. Biol Proced Online (2003) 0.94
Mutant membrane protein of the budding yeast spindle pole body is targeted to the endoplasmic reticulum degradation pathway. Genetics (2002) 0.94
The 19S proteasome subcomplex promotes the targeting of NuA4 HAT to the promoters of ribosomal protein genes to facilitate the recruitment of TFIID for transcriptional initiation in vivo. Nucleic Acids Res (2011) 0.94
The 19 s proteasome subcomplex establishes a specific protein interaction network at the promoter for stimulated transcriptional initiation in vivo. J Biol Chem (2009) 0.93
The ubiquitin-proteasome system regulates membrane fusion of yeast vacuoles. EMBO J (2006) 0.93
Ubiquitin on the move: the ubiquitin modification system plays diverse roles in the regulation of endoplasmic reticulum- and plasma membrane-localized proteins. Plant Physiol (2012) 0.93
Middle-down mass spectrometry enables characterization of branched ubiquitin chains. Biochemistry (2014) 0.92
Both K63 and K48 ubiquitin linkages signal lysosomal degradation of the LDL receptor. J Lipid Res (2013) 0.92
Novel CDC34 (UBC3) ubiquitin-conjugating enzyme mutants obtained by charge-to-alanine scanning mutagenesis. Mol Cell Biol (1995) 0.91
Monoubiquitination is sufficient to signal internalization of the maltose transporter in Saccharomyces cerevisiae. J Bacteriol (2000) 0.91
Intersection of the multivesicular body pathway and lipid homeostasis in RNA replication by a positive-strand RNA virus. J Virol (2011) 0.91
Proteasomal degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is mediated by the proteasome activator Blm10. Mol Biol Cell (2011) 0.90
Effects of cyclization on conformational dynamics and binding properties of Lys48-linked di-ubiquitin. Protein Sci (2007) 0.90
Ubiquitin initiates sorting of Golgi and plasma membrane proteins into the vacuolar degradation pathway. BMC Plant Biol (2012) 0.89
Neuronal ubiquitin homeostasis. Cell Biochem Biophys (2013) 0.88
The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system. Proc Natl Acad Sci U S A (2008) 0.87
Numerous proteins with unique characteristics are degraded by the 26S proteasome following monoubiquitination. Proc Natl Acad Sci U S A (2016) 0.87
The yeast C-type cyclin Ctk2p is phosphorylated and rapidly degraded by the ubiquitin-proteasome pathway. Mol Cell Biol (1999) 0.86
Mediator acts upstream of the transcriptional activator Gal4. PLoS Biol (2012) 0.83
Expression of a K48R mutant ubiquitin protects mouse testis from cryptorchid injury and aging. Am J Pathol (2003) 0.82
The ubiquitin-conjugating enzyme, UbcM2, is restricted to monoubiquitylation by a two-fold mechanism that involves backside residues of E2 and Lys48 of ubiquitin. Biochemistry (2014) 0.82
Polyubiquitin chain assembly and organization determine the dynamics of protein activation and degradation. Front Physiol (2014) 0.81
The recognition of ubiquitinated proteins by the proteasome. Cell Mol Life Sci (2016) 0.81
A Method for Analyzing the Ubiquitination and Degradation of Aurora-A. Biol Proced Online (2002) 0.80
Residues 240-250 in the C-terminus of the Pirh2 protein complement the function of the RING domain in self-ubiquitination of the Pirh2 protein. PLoS One (2013) 0.80
Identification of candidate substrates for the Golgi Tul1 E3 ligase using quantitative diGly proteomics in yeast. Mol Cell Proteomics (2014) 0.80
MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function. Oncotarget (2015) 0.80
Determination of ubiquitin fitness landscapes under different chemical stresses in a classroom setting. Elife (2016) 0.79
Nitric oxide increases lysine 48-linked ubiquitination following arterial injury. J Surg Res (2011) 0.77
Chemoenzymatic synthesis of bifunctional polyubiquitin substrates for monitoring ubiquitin chain remodeling. Chembiochem (2014) 0.77
Simultaneous detection of distinct ubiquitin chain topologies by 19F NMR. ACS Chem Biol (2014) 0.77
Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Mol Aspects Med (2016) 0.77
Intrinsic site-selectivity of ubiquitin dimer formation. Protein Sci (2015) 0.76
Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3). J Biol Chem (2015) 0.76
SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation. Sci Rep (2016) 0.76
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature. J Vasc Surg (2013) 0.75
Deubiquitinating enzymes Ubp2 and Ubp15 regulate endocytosis by limiting ubiquitination and degradation of ARTs. Mol Biol Cell (2017) 0.75
Canonical and Alternative Pathways in Cyclin-Dependent Kinase 1/Cyclin B Inactivation upon M-Phase Exit in Xenopus laevis Cell-Free Extracts. Enzyme Res (2011) 0.75
Importance of the N-terminal domain of the Qb-SNARE Vti1p for different membrane transport steps in the yeast endosomal system. PLoS One (2013) 0.75
A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet (1984) 35.54
Cyclin is degraded by the ubiquitin pathway. Nature (1991) 17.93
In vivo half-life of a protein is a function of its amino-terminal residue. Science (1986) 13.44
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell (1993) 12.41
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science (1989) 9.68
Structure of ubiquitin refined at 1.8 A resolution. J Mol Biol (1987) 9.19
The ubiquitin system for protein degradation. Annu Rev Biochem (1992) 8.84
The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature (1989) 8.69
Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell (1993) 6.84
Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell (1984) 6.81
The yeast polyubiquitin gene is essential for resistance to high temperatures, starvation, and other stresses. Cell (1987) 6.73
Selection of lys2 Mutants of the Yeast SACCHAROMYCES CEREVISIAE by the Utilization of alpha-AMINOADIPATE. Genetics (1979) 5.41
Ubiquitin-conjugating enzymes UBC4 and UBC5 mediate selective degradation of short-lived and abnormal proteins. EMBO J (1990) 5.31
A cyclin B homolog in S. cerevisiae: chronic activation of the Cdc28 protein kinase by cyclin prevents exit from mitosis. Cell (1991) 4.90
The N-end rule. Cell (1992) 4.80
The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature (1989) 4.70
The recognition component of the N-end rule pathway. EMBO J (1990) 4.55
A family of versatile centromeric vectors designed for use in the sectoring-shuffle mutagenesis assay in Saccharomyces cerevisiae. Gene (1988) 4.50
The yeast ubiquitin genes: a family of natural gene fusions. EMBO J (1987) 4.25
S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase. Nature (1993) 3.92
Ubiquitination. Annu Rev Cell Biol (1991) 3.48
The short-lived MAT alpha 2 transcriptional regulator is ubiquitinated in vivo. Proc Natl Acad Sci U S A (1991) 3.42
The multicatalytic and 26 S proteases. J Biol Chem (1993) 3.39
The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme. Proc Natl Acad Sci U S A (1991) 2.97
Epitope-tagged ubiquitin. A new probe for analyzing ubiquitin function. J Biol Chem (1991) 2.93
Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A (1991) 2.77
Ubiquitin as a degradation signal. EMBO J (1992) 2.73
Occurrence of a polyubiquitin structure in ubiquitin-protein conjugates. Biochem Biophys Res Commun (1985) 2.56
Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2. J Biol Chem (1994) 2.34
Resistance to cadmium mediated by ubiquitin-dependent proteolysis. Nature (1993) 2.22
Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J Biol Chem (1992) 2.08
The Pas2 protein essential for peroxisome biogenesis is related to ubiquitin-conjugating enzymes. Nature (1992) 1.98
Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84
Yeast RAD6 encoded ubiquitin conjugating enzyme mediates protein degradation dependent on the N-end-recognizing E3 enzyme. EMBO J (1991) 1.80
Structure of tetraubiquitin shows how multiubiquitin chains can be formed. J Mol Biol (1994) 1.76
Effect of heat shock on protein degradation in mammalian cells: involvement of the ubiquitin system. EMBO J (1987) 1.74
The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes. EMBO J (1992) 1.63
A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitin-mediated proteolysis. J Biol Chem (1990) 1.62
Expression of a ubiquitin derivative that conjugates to protein irreversibly produces phenotypes consistent with a ubiquitin deficiency. J Biol Chem (1992) 1.61
Ubiquitin conjugation by the yeast RAD6 and CDC34 gene products. Comparison to their putative rabbit homologs, E2(20K) AND E2(32K). J Biol Chem (1991) 1.55
Substrate properties of site-specific mutant ubiquitin protein (G76A) reveal unexpected mechanistic features of ubiquitin-activating enzyme (E1). J Biol Chem (1994) 1.54
Comparison of the three-dimensional structures of human, yeast, and oat ubiquitin. J Biol Chem (1987) 1.52
Ubiquitin C-terminal hydrolase activity associated with the 26 S protease complex. J Biol Chem (1993) 1.28
Binding sites of ubiquitin-protein ligase. Binding of ubiquitin-protein conjugates and of ubiquitin-carrier protein. J Biol Chem (1989) 1.27
Gene synthesis, expression, structures, and functional activities of site-specific mutants of ubiquitin. J Biol Chem (1987) 1.15
Ubiquitin-metallothionein fusion protein expression in yeast. A genetic approach for analysis of ubiquitin functions. J Biol Chem (1988) 1.15
Ubiquitin-mediated degradation of histone H3 does not require the substrate-binding ubiquitin protein ligase, E3, or attachment of polyubiquitin chains. J Biol Chem (1990) 1.05
A specific endpoint assay for ubiquitin. Proc Natl Acad Sci U S A (1987) 1.03
Structure and activities of a variant ubiquitin sequence from bakers' yeast. Biochemistry (1986) 0.96
Ubiquitin function studied by disulfide engineering. J Biol Chem (1989) 0.91
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science (1989) 9.68
Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol (2000) 9.16
RNAMotif, an RNA secondary structure definition and search algorithm. Nucleic Acids Res (2001) 4.96
Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A (2000) 3.83
A ubiquitin mutant with specific defects in DNA repair and multiubiquitination. Mol Cell Biol (1995) 3.56
Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell Biol (2000) 3.51
Ubiquitination. Annu Rev Cell Biol (1991) 3.48
The short-lived MAT alpha 2 transcriptional regulator is ubiquitinated in vivo. Proc Natl Acad Sci U S A (1991) 3.42
The multiubiquitin-chain-binding protein Mcb1 is a component of the 26S proteasome in Saccharomyces cerevisiae and plays a nonessential, substrate-specific role in protein turnover. Mol Cell Biol (1996) 3.41
p34Cdc28-mediated control of Cln3 cyclin degradation. Mol Cell Biol (1995) 3.23
Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci U S A (1987) 2.97
Human RNase III is a 160-kDa protein involved in preribosomal RNA processing. J Biol Chem (2000) 2.88
Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J (1995) 2.82
Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74
A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination. Proc Natl Acad Sci U S A (2000) 2.69
De novo initiation of viral RNA-dependent RNA synthesis. Virology (2001) 2.35
Prediction of rho-independent transcriptional terminators in Escherichia coli. Nucleic Acids Res (2001) 2.30
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry (1989) 2.26
Implication of RNA structure on antisense oligonucleotide hybridization kinetics. Biochemistry (1992) 2.17
Multiubiquitin chain binding and protein degradation are mediated by distinct domains within the 26 S proteasome subunit Mcb1. J Biol Chem (1998) 2.09
Proteasome inhibition measurements: clinical application. Clin Chem (2000) 2.04
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J Biol Chem (1992) 1.99
Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc Natl Acad Sci U S A (1994) 1.94
Mitomycin C: a review. Cancer Treat Rev (1976) 1.92
Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch Intern Med (1998) 1.92
The bacterially expressed yeast CDC34 gene product can undergo autoubiquitination to form a multiubiquitin chain-linked protein. J Biol Chem (1993) 1.86
Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res (2001) 1.85
Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84
Yeast metallothionein and applications in biotechnology. Microbiol Rev (1987) 1.82
Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res (1991) 1.80
Oligodeoxynucleotides containing 2'-O-modified adenosine: synthesis and effects on stability of DNA:RNA duplexes. Biochemistry (1993) 1.71
Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. Mol Biol Cell (2001) 1.69
Molecular cloning and complete amino-acid sequence of form-I phosphoinositide-specific phospholipase C. Nature (1988) 1.68
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem (1987) 1.66
Structure-activity relationships of novel 2-substituted quinazoline antibacterial agents. J Med Chem (1999) 1.63
A uniform isopeptide-linked multiubiquitin chain is sufficient to target substrate for degradation in ubiquitin-mediated proteolysis. J Biol Chem (1990) 1.62
Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway. Mol Cell Biol (1996) 1.61
Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat Rev (1979) 1.60
Iron uptake from ferrichrome A and iron citrate in Ustilago sphaerogena. J Bacteriol (1983) 1.60
Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci U S A (1989) 1.58
Ubiquitin conjugation by the yeast RAD6 and CDC34 gene products. Comparison to their putative rabbit homologs, E2(20K) AND E2(32K). J Biol Chem (1991) 1.55
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res (2007) 1.52
Properties of cloned and expressed human RNase H1. J Biol Chem (1999) 1.52
Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci U S A (1999) 1.48
Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J (1988) 1.42
Molecular cloning of sequences encoding the human heat-shock proteins and their expression during hyperthermia. Gene (1986) 1.42
Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain. Proc Natl Acad Sci U S A (1988) 1.41
Topoisomerase II alpha and topoisomerase II beta genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res (1992) 1.39
Kinetic characteristics of Escherichia coli RNase H1: cleavage of various antisense oligonucleotide-RNA duplexes. Biochem J (1995) 1.39
Comprehensive reform of the new drug regulatory process. Biotechnology (N Y) (1995) 1.38
Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element. Nucleic Acids Res (1991) 1.37
Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells. Mol Pharmacol (1988) 1.35
Siderophore iron transport followed by electron paramagnetic resonance spectroscopy. J Biol Chem (1982) 1.33
Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320). AIDS Res Hum Retroviruses (1994) 1.33
Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci U S A (1989) 1.30
Cloning and expression of a yeast copper metallothionein gene. Gene (1984) 1.30
Yeast metallothionein function in metal ion detoxification. J Biol Chem (1986) 1.28
Bleomycin, a review. J Med (1976) 1.26
Identification and isolation of a mammalian protein which is antigenically and functionally related to the phospholipase A2 stimulatory peptide melittin. J Biol Chem (1987) 1.26
Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J Biol Chem (1995) 1.24
Functional and physical characterization of the cell cycle ubiquitin-conjugating enzyme CDC34 (UBC3). Identification of a functional determinant within the tail that facilitates CDC34 self-association. J Biol Chem (1994) 1.24
Role of two siderophores in Ustilago sphaerogena. Regulation of biosynthesis and uptake mechanisms. Biochim Biophys Acta (1982) 1.23
Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids. Biochemistry (1997) 1.23
Recognition and transport of ferric enterobactin in Escherichia coli. J Bacteriol (1986) 1.21
In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration. J Pharmacol Exp Ther (1998) 1.20
Specific recognition of calmodulin from Dictyostelium discoideum by the ATP, ubiquitin-dependent degradative pathway. J Biol Chem (1985) 1.20
Crystal structure of a class I ubiquitin conjugating enzyme (Ubc7) from Saccharomyces cerevisiae at 2.9 angstroms resolution. Biochemistry (1997) 1.20
In vivo resistance towards anthracyclines, etoposide, and cis-diamminedichloroplatinum(II). Cancer Res (1982) 1.18
Tertiary structures of class I ubiquitin-conjugating enzymes are highly conserved: crystal structure of yeast Ubc4. Biochemistry (1993) 1.18
Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem (1986) 1.17
PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells. J Biol Chem (1997) 1.17
Gait problems in diabetic neuropathic patients. Arch Phys Med Rehabil (1996) 1.16
Vitravene--another piece in the mosaic. Antisense Nucleic Acid Drug Dev (1998) 1.16
Gene synthesis, expression, structures, and functional activities of site-specific mutants of ubiquitin. J Biol Chem (1987) 1.15
Ubiquitin-metallothionein fusion protein expression in yeast. A genetic approach for analysis of ubiquitin functions. J Biol Chem (1988) 1.15
Cleavage of single strand RNA adjacent to RNA-DNA duplex regions by Escherichia coli RNase H1. J Biol Chem (1997) 1.15
Increasing gene expression in yeast by fusion to ubiquitin. J Biol Chem (1989) 1.14
Cloning of a phospholipase A2-activating protein. Proc Natl Acad Sci U S A (1991) 1.13
Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation. Proc Natl Acad Sci U S A (1981) 1.13
Antitumor activity of antisense clusterin oligonucleotides is improved in vitro and in vivo by incorporation of 2'-O-(2-methoxy)ethyl chemistry. J Pharmacol Exp Ther (2001) 1.12
Triggered activity in the heart: cellular mechanisms of early after-depolarizations. Eur Heart J (1991) 1.12
Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol (2001) 1.11
Purification, characterization, and structural properties of a single protein from rat basophilic leukemia (RBL-1) cells possessing 5-lipoxygenase and leukotriene A4 synthetase activities. Mol Pharmacol (1986) 1.11
Clinically silent preoperative brain injuries do not worsen with surgery in neonates with congenital heart disease. J Thorac Cardiovasc Surg (2010) 1.10
Investigating the structure of human RNase H1 by site-directed mutagenesis. J Biol Chem (2001) 1.09
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep (1980) 1.09
Purification and characterization of a phosphoinositide-specific phospholipase C from guinea pig uterus. Phosphorylation by protein kinase C in vivo. J Biol Chem (1987) 1.09
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res (1987) 1.09
Characterization of a dominant negative mutant of the cell cycle ubiquitin-conjugating enzyme Cdc34. J Biol Chem (1995) 1.08
Modern war surgery: the experience of Bosnia. 2: The clinical experience. Can J Surg (1995) 1.08
Gene synthesis, expression, and processing of human ubiquitin carboxyl extension proteins. J Biol Chem (1989) 1.07